Nyxoah (NYXH) to Release Quarterly Earnings on Tuesday

Nyxoah (NASDAQ:NYXHGet Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect Nyxoah to post earnings of ($0.48) per share for the quarter.

Nyxoah Trading Down 2.0 %

NASDAQ:NYXH opened at $10.04 on Friday. The company has a 50-day moving average price of $9.93 and a 200-day moving average price of $9.06. The stock has a market cap of $341.96 million, a price-to-earnings ratio of -5.37 and a beta of 1.40. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. Nyxoah has a 12 month low of $6.76 and a 12 month high of $20.00.

Wall Street Analyst Weigh In

Several analysts have weighed in on NYXH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $16.00 price objective on shares of Nyxoah in a research report on Tuesday, November 5th. HC Wainwright restated a “buy” rating and issued a $17.00 target price on shares of Nyxoah in a research note on Friday, December 13th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $17.00.

Check Out Our Latest Report on NYXH

Nyxoah Company Profile

(Get Free Report)

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

Further Reading

Earnings History for Nyxoah (NASDAQ:NYXH)

Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.